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Abstract
Background: Every year, about 15 million of the world’s infants are born preterm (before 37 weeks gestation). In
Alberta, the preterm birth rate was 8.7% in 2015, the second highest among Canadian provinces. Approximately
20% of preterm infants are born before 32 weeks gestation (early preterm), and require care in a Level III neonatal
intensive care unit (NICU); 80% are born moderate (32 weeks and zero days [320/7] to 336/7 weeks) and late preterm
(340/7 to 366/7 weeks), and require care in a Level II NICU. Preterm birth and experiences in the NICU disrupt early
parent-infant relationships and induce parental psychosocial distress. Family Integrated Care (FICare) shows promise
as a model of care in Level III NICUs. The purpose of this study is to evaluate length of stay, infant and maternal clinical
outcomes, and costs following adaptation and implementation of FICare in Level II NICUs.
Methods: We will conduct a pragmatic, cluster randomized controlled trial (cRCT) in ten Alberta Level II NICUs
allocated to one of two groups: FICare or standard care. The FICare Alberta model involves three theoretically-
based, standardized components: information sharing, parenting education, and family support. Our sample
size of 181 mother-infant dyads per group is based on the primary outcome of NICU length of stay, 80% participation,
and 80% retention at follow-up. Secondary outcomes (e.g., infant clinical outcomes and maternal psychosocial distress)
will be assessed shortly after admission to NICU, at discharge and 2 months corrected age. We will conduct economic
analysis from two perspectives: the public healthcare payer and society. To understand the utility, acceptability, and
impact of FICare, qualitative interviews will be conducted with a subset of mothers at the 2-month follow-up, and
with hospital administrators and healthcare providers near the end of the study.
Discussion: Results of this pragmatic cRCT of FICare in Alberta Level II NICUs will inform policy decisions by providing
evidence about the clinical effectiveness and costs of FICare.
Trial registration: ClinicalTrials.gov, ID: NCT02879799. Registered on 27 May 2016. Protocol version: 9 June 2016;
version 2.
Keywords: Infant, Premature, Family integrated care, Patient engagement, Randomized controlled trial,
Parenting education, Nursing, Cost-effectiveness
* Correspondence: benzies@ucalgary.ca
1Faculty of Nursing, Department of Paediatrics, University of Calgary, PF 2278,
2500 University Drive, NW, Calgary, AB T2N 1N4, Canada
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Benzies et al. Trials  (2017) 18:467 
DOI 10.1186/s13063-017-2181-3
Background
Preterm Birth
Each year, about 15 million of the world’s infants are
born preterm before 37 weeks gestation [1]. The
preterm birth rate in Alberta, 8.7% in 2015, is the second
highest among Canadian provinces [2]. These rates may
be attributed, in part, to delayed childbearing [3, 4] and
assisted reproductive technology [5, 6]. Approximately
20% of preterm infants are born before 32 weeks
gestation (early preterm) [7], and require care in a
Level III neonatal intensive care unit (NICU) [8]. The
remaining 80% are born moderately preterm (32 weeks
and zero days [320/7] to 336/7 weeks gestational age [GA])
and late preterm (340/7 to 366/7 weeks GA) [9]. In Alberta,
6.6% of live births, or approximately 3500 infants annually
[10], require care in a Level II NICU [8]. Compared with
their full-term counterparts, preterm infants who survive
are at higher risk for short-term morbidities including
respiratory problems [11], hyperbilirubinemia [12], infec-
tions [13], and hypoglycemia [12], as well as long-term
adverse neurodevelopmental outcomes including cogni-
tive delays [14–16], visual [17, 18] and hearing impair-
ments [18], and behavioral problems [14, 19–21]. Further,
as GA decreases, the risk of chronic health problems and
developmental delays increases [22, 23].
Cost of preterm birth
The costs associated with preterm infants are greater
than for term infants because of increased (1) hospital
length of stay (LOS), (2) resource utilization, (3) read-
missions, and (4) need for additional health, educa-
tion, and social services in the community [24, 25].
In 2010, care of preterm infants represented the
largest category of Alberta’s expenditures for pediatric
health care at 8.45%, with a total cost of approxi-
mately $35 million Canadian Dollar (CAD) [26]. Simi-
lar to health consequences of preterm birth, there is a
reverse economic gradient associated with GA [27].
That is, the lower the GA, the greater healthcare sys-
tem and out-of-pocket expenses for parents of pre-
term infants. In Canada, recently estimated costs per
infant to age ten years were $67,467 CAD for chil-
dren born before 28 weeks GA, $52,796 CAD for
those born between 28 and 32 weeks GA, and
$10,010 CAD for those born between 33 and 36 weeks
GA [28]. Financial consequences for parents include
reduced workforce participation and lost earnings, as
well as the cost of developmental supports for the in-
fant [29]. Unquantifiable costs are associated with
psychological distress, marital distress, and social iso-
lation [29]. Although effective psycho-educational in-
terventions for mothers of preterm infants exist [30],
evidence is generally limited to the extremely preterm
infants and cost-effectiveness data are lacking.
Level II neonatal intensive care for preterm infants and
their families
Level II NICUs are technological, critical care environ-
ments where healthcare providers (HCP) often uninten-
tionally marginalize parents in the pursuit of optimal
clinical care of preterm infants [31]. The unexpected
birth of a preterm infant may leave parents feeling
anxious, depressed, isolated, and unprepared to interact
with, and care for, their infant [32]. Preterm birth and
experiences in the NICU may disrupt breastfeeding [33]
and the early parent-infant relationships [34] that are
critical for early brain and biological development [35, 36].
Systematic reviews and meta-analyses of interventions
for parents of preterm infants suggest that psycho-
educational approaches increase maternal self-efficacy,
reduce anxiety and depression [37], and increase
human-milk feeding [37], with consequent improve-
ments in child development [37]. However, many of
these interventions predate evidence of the import-
ance of early parent-child relationships to life-long
health [35, 36].
A new model of care, Family Integrated Care (FICare),
shows promise as an intervention to improve outcomes
for early preterm infants cared for in Level III NICUs
[38–40]. Based on these promising results, FICare is
being evaluated in two cluster randomized controlled
trials (cRCTs): one is a 26-site international (Canada,
Australia, New Zealand) trial [41], and one a 6-site trial
in China [42]. Another Canadian study using a pre-test/
post-test design in Level II NICUs is currently in
progress. None of these studies focus on health system
impact, nor include an economic analysis. Thus, a
pragmatic cRCT [43] is critical to inform health service
decisions about clinical effectiveness and costs of FICare
for moderate and late preterm infants admitted to
Level II NICUs and their families.
Objectives and hypotheses
The objective of this study is to adapt FICare for imple-
mentation in Level II NICUs across Alberta, and evalu-
ate its clinical effectiveness and costs. We hypothesize
that FICare will empower parents with the knowledge,
skill and confidence to care for their infant(s), and pre-
pare the family for earlier discharge with a concomitant
decrease in NICU LOS (primary outcome). Secondarily,
we hypothesize that FICare will (1) reduce infant
morbidities during hospitalization and the risk of devel-
opmental delay at 2 months corrected age (CA), (2)
increase rates of human-milk feeding by discharge and
at 2 months CA, and (3) reduce parental psychological
distress by discharge and at 2 months CA. To under-
stand the utility, acceptability, and impact of FICare,
qualitative interviews will be conducted with a subset of
mothers at the 2-month-old follow-up, and with hospital
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administrators and HCP near the end of the study. The
specific objectives of the economic analysis are three-
fold: (1) to estimate the implementation costs of FICare,
(2) to compare public healthcare payer costs of FICare
against standard care, and (3) to compare societal costs
during hospitalization for parents of FICare against
standard care.
Methods
Study design
The proposed study employs a pragmatic, parallel-
group, superiority cRCT [44] with convenience
sampling. A cRCT will avoid contamination between
groups, particularly in smaller cities that have only one
Level II NICU. The study design and adaptation of the
FICare intervention for Alberta Level II NICUs were co-
developed by a provincial, multidisciplinary stakeholder
group. We adhered to Consolidated Standards of Report-
ing Trials (CONSORT) and Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
guidelines in the design of the protocol (Additional file 1).
A qualitative component will describe maternal, hospital
administrator, and HCP experiences of FICare, the process
of implementation itself, and implementation quality.
Setting
We will conduct the study in ten Level II NICUs (five
intervention and five control sites) across the province
of Alberta, which is located in Western Canada. Alberta’s
population of four million is typically younger with
higher income, and a greater proportion of women in
their childbearing years than the Canadian average [45].
Alberta has a single, publicly funded health services
delivery system (Alberta Health Services [AHS]), which
offers advantages for multicenter studies in terms of
standardization of many structures and processes across
hospitals in the province. All hospitals serve a demograph-
ically diverse population that is generally representative of
the care of childbearing women in Alberta. AHS HCP must
be registered members under the provincial Health Disci-
plines Act (see http://www.qp.alberta.ca/documents/Acts/
H02.pdf). For a list of study sites, see http://www.ucalgar-
y.ca/ficare/ficare-alberta/partnerships.
We will coordinate the trial through a central office in
the Faculty of Nursing, University of Calgary. Study co-
ordinators will liaise daily or weekly, as needed, with
study nurses to ensure that recruitment targets are being
met, data collection is accurate and timely, and fidelity
to their group allocation is maintained.
All study nurses (registered or licensed practical
nurses) will be employees of AHS, and will receive 4 h
of specialized training about (1) the purpose of the
FICare study, (2) consenting participants, and (3) data
collection. We will provide training “booster doses”
when fidelity checks warrant them. For the intervention
sites only, we will use a “train-the-trainer” model to
provide education about FICare to all HCP at the site.
To facilitate study nurses to deliver training at the
FICare intervention sites, we will provide an additional
8 h of training about the Alberta Level II NICU FICare
model. All HCP in Level II NICUs in this study are
generally aware of the principles of patient and family
centered care prior to implementation because that is
a pillar of care for AHS. However, HCP do not
receive specialized training in either family centered
care or FICare.
Eligibility criteria for clusters
All ten Level II NICUs (clusters) across six cities in
Alberta were eligible and agreed to participate in the
trial. The loss of a cluster would jeopardize completion
of this study. To decrease potential loss of sites, we will
ensure frequent and effective communication between
the coordinating and local sites. To prevent loss of
clusters due to: (1) lack of resources, the study will
provide a proportion of the salary for a FICare study
nurse to each site to support study activities, and (2)
resentful demoralization, we budgeted to provide
training to control clusters at the end of the study if
FICare is effective.
Eligibility criteria for individual participants
We will include mothers and their preterm infants born
between 320/7 weeks to 346/7 weeks GA with a primary
admission, or transfer within 72 h, to one of the Level II
NICUs. Thirty-two weeks and zero days is the minimum
GA for an infant admitted to a Level II NICU; otherwise
the infant should be admitted or transferred to a Level III
NICU [8]. If otherwise healthy, preterm infants are typ-
ically discharged around 360/7 weeks. Thus, 346/7 weeks
is the maximum GA at enrollment that will ensure a
minimum of 1 week of exposure to FICare. We will con-
firm GA by first trimester ultrasound or date of last
menstrual period, as recorded on the infant’s medical
record. We will exclude mothers (1) whose health, so-
cial, or language issues may inhibit their ability to com-
municate with the healthcare team, (2) with triplets or
higher-order multiple births who may be overwhelmed
with their care, or (3) whose infants require palliative
care or have severe congenital or chromosomal anomal-
ies. We will include mothers in the intervention group if
they agree to spend a minimum of 6 h per day with their
infant.
Trial arms
FICare intervention group
Mothers and their infant(s) in each cluster allocated to
the intervention group will receive FICare for Alberta
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Level II NICUs as the routine care. We adapted the
Alberta Level II NICU model of FICare from a four-
pillar model established for Level III NICUs [38]. The
four-pillar model consists of: (1) staff education and sup-
port, (2) parent education, (3) NICU environment, and
(4) psychosocial support [38]. Given that (1) preterm in-
fants admitted to a Level II NICU are more mature than
infants admitted to a Level III NICU and have a shorter
LOS, and (2) because provincial health services are de-
livered through two providers (Alberta Health Services
and Covenant Health), there were questions about the
goodness of fit. Following consultation with provincial
stakeholders, we reconceptualized the FICare four-pillar
model to better fit the Level II NICU population and
context for the current cRCT.
FICare for Alberta Level II NICUs is a dynamic,
psycho-educational intervention with three main com-
ponents: (1) information sharing (during one-to-one re-
lational communications and bedside rounds), (2) parent
education (one-to-one and group sessions) supported by
technology and defined learning pathways, and (3)
parental support from professionals (formal) and veteran
parents (informal). Veteran parents [46] are those who
have had previous experience with their own moderate
or late preterm infant in a Level II NICU. The goal of
FICare is a change in culture and practice that permits,
encourages, and supports parents in their parenting role
while their infant is receiving care in a Level II NICU.
Underpinned by developmental neuroscience [47], rela-
tional communications [48], and adult learning [49] and
change [50] theories, FICare empowers parents to
sequentially build their knowledge, skill, and confidence
so that they are well-prepared to care for their infant
long before discharge. This model is dynamic whereby
parents and HCP use relational communication skills to
negotiate mutually equitable roles during the infant’s
NICU stay [48]. Thus, roles change dynamically with the
infants’ progress and as parents learn to provide care.
For example, at admission nurses may provide 90% of
the infant’s care and parents provide 10%; nearer to the
time of discharge, parents provide 90% of the care and
nurses provides 10%.
Standard care control group
Mothers and their infant(s) in the control group will
continue to receive standard care. Because this is a
pragmatic trial conducted in a progressive and dynamic
health system, we will carefully track any changes to
policy and practice that may influence outcomes of the
FICare study. For example, a secondary outcome of this
study is related to frequency of administering incorrect
human donor-milk. To reduce donor-milk errors, AHS
recently implemented a bar-coding system in several
NICUs, including two control and one intervention
clusters. We recorded the dates of training and imple-
mentation for bar coding and will consider the new
procedure when interpreting the results.
Contamination of intervention
There are three Level II NICUs in each of the two larger
cities, and at least one of the hospitals in each city was
randomized to the FICare intervention group. Thus,
there is a risk of contamination in the larger cities
because casual and part-time nurses and physicians may
work at more than one site. We will include nurses in
FICare training based on the primary site of their
employment. We will ask administrators and HCP in the
FICare group not to discuss the study outcomes with
colleagues in the standard care group. We will tell
families of infants the purpose of the study (to compare
different models of care) and requirements to partici-
pate, but not give details about FICare. We will carefully
track other research studies and practice changes at all
sites during the study period to monitor for synergistic
and spin-off effects of FICare.
Site randomization
The biostatistician (LP-D) stratified the ten participat-
ing Level II NICUs by size (large and small). Given the
desire to have the randomization stratified to ensure
balance of standard of care (control) or intervention
(FICare) in each stratum, we conducted a simple
random sampling within stratum. Given the small sam-
ple size in each stratum (four small and six large cen-
ters), there was no possibility of creating random-sized
blocks to try to do a better allocation concealment or
to be able to reduce predictability. Each study group
has an equal number of small and large clusters. Group
allocation was unknown to any other team member
prior to an announcement to provincial stakeholders by
LP-D during a telehealth meeting.
Blinding
The FICare intervention cannot be blinded; therefore,
group allocation cannot be concealed. We will blind data
analysts, and the research assistants from the AHS
Workforce and Evaluation who are conducting qualita-
tive interviews. We will supervise data analysts, but will
not provide any information about the purpose of the
study nor group allocation. In the datasets, we will code
hospital name and study group to prevent identification.
Sample size estimate
The sample size estimate for this trial is based on the
primary outcome, which is the comparison of LOS
between groups. On average the Level II NICU LOS is
16 days; we expect a reduction of 10% (1.6 days) with
FICare. Given that LOS has a skewed distribution, we
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used a natural logarithm transformation to estimate
sample size [51]. We estimated sample size based on an
inter-class correlation (ICC) of 0.18 (obtained from 2013
aggregated administrative data of the ten participating
hospitals), standard deviation (SD) in a natural logarithm
scale of 0.235 (assuming equal variances between treat-
ment and control groups), a two-tail test with a signifi-
cance level of 0.05, and a power of 0.80, taking into
account unequal cluster sizes [44]. To achieve a power
of 0.80 to analyze the primary outcome, we need to
approach 227 mothers per group to achieve an effective
sample size of 181 per group (total 362).
There are sufficient moderate and late preterm infants
to achieve our estimated sample size within 1 year. On
average, each Level II NICU unit has 103 infants in our
gestation range admitted in 9 months, with a potential
total of 1030 infants admitted to the ten sites. With an
expected 80% participation rate [38] we will have a
potential of 824 mother participants. We will exceed the
minimum sample size required to analyze the primary
outcome (LOS) so that we can account for those
mothers who we recruit and whose infant stays less than
1 week (6%), and to allow us to carry out mixed-effect
analysis to answer the primary research question. For
the follow-up at 2 months, we estimate an 80% retention
rate to follow-up (824 × 0.80 = 659). Thus, our sample
size will also allow us to analyze secondary outcomes,
including those that will be measured at 2 months.
Recruitment
We will have similar recruitment procedures across clus-
ters. A study nurse will use a standardized script to
inform mothers of the study within 72 h of the birth and
primary admission or transfer of their infant(s) to a
Level II NICU. For interested mothers, the study nurse
will (1) screen for eligibility, (2) answer questions about
the study, and (3) obtain written informed consent.
Infants of mothers who do not wish to participate in the
study will still receive either FICare or standard care,
depending on the group allocation of their hospital. We
will offer mothers in the intervention group a hospital
parking pass to enable them to spend a minimum of 6 h
per day in the Level II NICU with their infant(s). We will
account for the cost of hospital parking passes for mothers
in the intervention group in the economic analyses.
Participant timeline
Mothers in both groups will complete baseline question-
naires as soon as they are well enough, within 72 h of
the admission or transfer of their infant(s) to the NICU.
The study protocol is based on the SPIRIT Figure (see
Fig. 1 for details). Approximately 24 h prior to the
expected hospital discharge of their infant(s), mothers
will complete outcome questionnaires. Daily, all mothers
will complete an investigator-designed (KB and IW)
Parent Journal to capture out-of-pocket costs for
economic analyses. In addition to cost information, the
version of the Parent Journal for the intervention group
includes a place to record daily updates on infant weight
gain/loss, feeding, apneic and bradycardia episodes, and
questions for the multidisciplinary healthcare team
during bedside rounds. The intervention group Parent
Journal also includes a checklist for the mother to
record educational and support activities.
Immediately following infant discharge, and before the
chart is dispatched to medical records, study nurses will
collect data from the infant medical record and enter it
into a web-based survey platform. In the event that the
study nurses cannot complete infant discharge data
collection (e.g., nursing staff transition), a research
assistant will travel to the site and complete the infant
discharge data collection.
When the infant(s) is/are age 2 months CA, the
central coordinating site staff will collect and enter
follow-up data from mothers, including information
about infant development, feeding, hospital readmis-
sions, and physician visits that are additional to the
recommended health surveillance visits [52]. Data
collectors cannot be blinded to group allocation at the
2-month CA follow-up because they require address and
telephone number with area code to contact mothers.
This information can reveal the site where the mother is
currently living and the likely location of the birth of her
preterm infant. Mothers have the option of completing
the follow-up survey via their own computer using an
on-line link, or via the telephone. For the duration of
the trial, the central coordinating site staff will monitor
events and activities that could be attributed to imple-
mentation of FICare or influence outcomes of the
FICare study.
Outcomes
Primary outcome: LOS in Level II NICUs, which will
be measured as number of days between admission
and discharge.
Secondary outcomes: (1) number of nosocomial infec-
tions between admission and discharge, (2) number of
adverse events (e.g., medication and donor breast-milk
errors) between admission and discharge, (3) number of
times infants had feeding suspended (NPO) with con-
comitant interventions including initiation of intravenous
starts and sepsis workups between admission and dis-
charge, (4) number of hospital readmission rates, emer-
gency room visits, and unplanned physician visits
(additional to recommended pediatric health surveillance
visits) [52] between discharge for birth hospitalization and
2 months CA, (5) scale scores on maternal psychosocial
distress (stress, depression, anxiety) at baseline (enrollment),
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discharge and 2 months CA, (6) scale score on maternal
confidence in caring for their infant at baseline, discharge,
and 2 months CA, (7) proportion of infants receiving
breast-milk feeding at discharge and 2 months CA; (8) scale
scores on maternal breastfeeding self-efficacy at baseline,
discharge, and 2 months CA, and (9) proportion of infants
who score in the referral zone on a child develop-
mental screener at 2 months CA. See Table 1 for
scales and screener used in the admission, discharge,
and 2-month CA follow-up.
Qualitative component: (1) We will capture maternal
experiences of FICare related to expectations of care,
Fig. 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) schedule of enrollment, interventions, and assessments
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support for breastfeeding, and preparation for discharge,
(2) we will capture HCP and hospital administrators’ ex-
periences of FICare related to workload, staff satisfac-
tion, and the various processes and structures at each
site. These qualitative data will capture the process of
implementation itself, and implementation quality will
be coded within the five domains of the Consolidated
Framework for Implementation Research [53]. The
Damschroeder framework [53] will ensure a systematic
and succinct assessment of implementation within a
provincial healthcare organization.
Economic evaluation: the economic evaluation will
compare direct and indirect costs between the FICare
and standard care groups. Direct cost refers to health
system costs: nursing time, clinical supplies, medica-
tions, hospitalizations, and physician visits additional to
the recommended pediatric health surveillance visits in
Canada [52]. The average hospital LOS for infants
admitted to a Level II NICU in Alberta is 16 days, with
an average per diem cost of $788 CAD [26]. In 2014, it
cost Alberta approximately $43,459,776 CAD (3447 in-
fants × $788 per day × 16 days) to provide Level II NICU
care for moderate and late preterm infants. If FICare can
reduce the hospital LOS by 10% (1.6 days), this would
reduce costs to $39,113,798 CAD, which would be a cost
saving of $4,345,978 CAD per year. This cost saving
does not include hospital readmissions, emergency de-
partment, or physician visits additional to the recom-
mended health surveillance visits (data for estimations
not available at the time of grant submission). While dir-
ect healthcare system costs are of key importance to the
health system, the indirect (out-of-pocket) costs of
Table 1 Study measures
Measure Time point and metric Description
Parental Stressor Scale:
(PSS: NICU) [61]
Change in total and subscale scores
between baseline and discharge
50-item scale that captures parental perceptions of stress in the NICU:
(1) sights and sounds, (2) appearance and behavior of the infant, (3)
impact on the parental role and relationship with the infant, and (4)
parental relationship and communications with staff. Internal consistency
(0.89 to 0.94 for the total scale) and test-retest (0.87) reliabilities are high
Parenting Stress Index -
Short Form
(4th ed.) [62]
Total and subscale scores at
2 months CA
36-item scale that captures general parenting stress as well as the
three subscales of Parental Distress, Parent-Child Dysfunctional
Interaction, and Difficult Child. Internal consistency (0.91 for Total
Stress, 0.80 to 0.87 for subscales) and test-retest (0.84 for Total Stress,
0.68 to 0.84 for subscales) reliabilities are acceptable
Edinburgh Postnatal
Depression Scale [63]
Change in total score and proportion
in the clinical range (≥13) between
baseline discharge and 2 months CA
The most commonly used pre- and postnatal depression screener
validated for mothers. Consists of 10 items and has a sensitivity of
0.86 and specificity of 0.78, with a positive predictive value of 73%
State-Trait Anxiety Inventory
(STAI) [64]a
Change in total score on State Anxiety
between baseline, discharge and
2 months CA controlling for Trait
Anxiety
40-item scale that captures dispositional/trait anxiety (20 items) and
current state anxiety (20 items). Internal consistency (0.86 to 0.95) and
test-retest (0.73 to 0.86) reliabilities are high. Scores on the STAI and
PSS: NICU are correlated [61].
Perceived Maternal Parenting
Self-Efficacy
scale [65]b
Change in total score on between
baseline discharge and 2 months CA
20-item measure of parenting self-efficacy validated for mothers of
preterm infants. Captures maternal perceptions of ability to (1) give
basic care, (2) elicit change in infant behavior, (3) recognize infant
behavior, and (4) judge interactions with her infant. Exploratory factor
analysis confirms four factors; internal consistency (0.91) and test-retest
(0.96) reliabilities are high
Modified Breastfeeding Self-
Efficacy Scale - Short Form [66]
Change in total score and subscale
scores between baseline, discharge
and 2 months CA
18-item scale validated for mothers of ill and/or preterm infants.
Assesses a mother’s confidence in her ability to breastfeed when her
infant is ready on four subscales: (1) performance accomplishments,
(2) vicarious experience, (3) verbal persuasion, and (4) physiological responses.
Internal consistency (0.88) is high
Ages and Stages Questionnaires
(3rd ed.) (ASQ-3) [67]
Proportion of infants in the referral
zone at 2 months CA
A widely used developmental screening instrument consisting of 21
age-appropriate questionnaires, with 30 items each, for use with infants
and children 1 to 66 months of age. Assesses development in five
domains: communication, gross motor, fine motor, problem-solving,
and personal-social. For each domain, cut-off scores have been
empirically derived for (a) appropriate development, (b) monitoring zone
(≥1 and < 2 standard deviations below the mean), and (c) referral
(2 standard deviations below the mean). The ASQ-3 has strong
psychometric properties, including high sensitivity (0.86) and specificity
(0.85) [68], and has been evaluated and recommended as an effective
screener of global development in moderate and late preterm infants
[23, 69, 70]
Note. aAt admission, both State and Trait forms are completed; at discharge and 2 months CA, only the State form is completed; bCompleted only by mothers
who are breastfeeding
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preterm birth have an impact on parents and other sib-
lings in the family. For example, parents must pay out-
of-pocket for parking, transportation, household sup-
port, and childcare for siblings while the infant is in hos-
pital. In addition to time lost from work, parents may
need to travel long distances to be near their hospital-
ized infant(s), and pay for food and accommodation. We
will continue to capture direct healthcare system costs
(e.g., hospital readmissions, emergency department visits)
until the 2-month CA follow-up.
Data collection, management, and analysis
Data collection
We define the primary outcome (LOS) as the time in
days from birth (admission) to discharge. The attending
physician determines infant discharge criteria based on
infant wellness and parental caregiving capacity. We will
measure secondary outcomes using a combination of
health administrative data, parent-reported survey infor-
mation, and self-reported scales. We will used semistruc-
tured interviews to explore mothers’ and HCP experiences
of FICare. To estimate indirect costs and validate adminis-
trative data, we will ask parents to keep a daily diary of their
expenses while their infant(s) is/are in the NICU.
Except in the rare case of maternal preference or
equipment failure when mothers will complete a paper
version of the questionnaires, mothers in both groups
will use electronic tablets to complete questionnaires.
FluidSurveys was planned as the data collection platform
for this cRCT. When FluidSurveys was purchased by
SurveyMonkey, which refused to extend research
contracts, we needed to convert to Qualtrics (see
https://www.qualtrics.com/). In the web-based survey,
automatic skip patterns will ensure that mothers
complete only relevant sections of questionnaires at each
time point. For example, if a mother indicates that she
does not intend to breastfeed, the section about breast-
feeding self-efficacy is automatically bypassed. We gave
careful consideration to the ethical principle of auton-
omy in requiring a response before a mother can
proceed to the next question without skipping an
answer. Except for scales with previously defined
response categories, the majority of survey items include
a “prefer not to answer” option.
Data management
We will collect data electronically. Once downloaded
from the web-based platform and transferred to statis-
tical software, we will examine data for missing values
and patterns of missing values. Where appropriate and
recommended by scale developers, we will replace miss-
ing values on scales or subscales with the mean score on
that item for the group (intervention or control).
We will store data on University of Calgary servers
that are backed-up daily. The servers are accessible only
via university-managed, timed-out, password-protected
computers. Permission for access to these computers
can be granted only by investigator KB. These com-
puters are located in dedicated, locked with key-entry re-
search offices accessible only by research staff and
designated graduate students. Investigator KB requires
that all study investigators, research staff and students
have (1) completed the Tri-Council Policy Statement:
Ethical Conduct for Research Involving Humans (TCPS-2)
certification, (2) a profile with their ethics board, and (3)
signed a study-specific confidentiality agreement.
Once data are cleaned and the majority of analyses are
complete, we will store anonymized data for those study
participants who have consented. To facilitate data
access by other qualified researchers, we consulted with
PolicyWise Secondary Analysis to Generate Evidence
(SAGE; formerly the Child Data Centre of Alberta) to
ensure that consent and other data management pro-
cesses are aligned with best practice for data storage
(see https://policywise.com/initiatives/sage/).
Data analysis
We will aggregate outcomes (e.g., LOS, adverse events)
across individuals, and compare the FICare group
against the control group. We will perform intention-to-
treat analyses. We will present numerical variables as
means (SD) or medians (interquartile-range), and
categorical variables as counts and percentages (with
95% confidence interval). We will use a significance level
(α) of 0.05.
To compare LOS, the primary outcome, between
FICare and standard care groups, we will use a t-test,
taking into account clustering and the unequal cluster
sizes. We will use a natural log transformation given that
LOS has a skewed distribution [51]. For secondary
analyses at the individual mother and infant level, we
will perform a linear mixed-effects model to evaluate if
the effect of FICare is confounded by demographic,
infant and maternal health, and health system covariates.
We will perform sensitivity analysis by removing
mothers and/or their infants who were transferred
between sites. We will analyze the secondary outcomes
using t-tests for numerical outcomes and chi-square
tests for categorical variables, adjusting for clustering.
We will analyze secondary outcomes measured at more
than one point in time using generalized linear-mixed
models. We will not correct for multiple comparisons
because we have only one primary research question. An
additional secondary outcome available at the cluster
level is adverse events including medication or human-
milk administration errors captured through the AHS
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Reporting and Learning System. We will describe this
outcome with ranges for each group.
Economic analyses
We will conduct the economic analyses using data
collected prospectively alongside the study (i.e., during the
hospital stay and at 2 months CA) from Parent Journals,
study questionnaires, and administrative databases such as
Data Integration, Measurement, and Research (DIMR)
and discharge abstracts for hospitalizations, pharmacy,
and laboratory services. First, we will conduct a cost
analysis to estimate the total cost of FICare. We will iden-
tify the activities involved in the implementation of FICare
and estimate the cost required to implement the interven-
tion. Second, since the primary effectiveness outcome is
LOS, which can be expressed in monetary terms (i.e.,
hospitalization cost), we will analyze the relative costs of
FICare and standard care. The main outcome of the
second objective will be the incremental difference in cost
between FICare and standard care during hospitalization
and at 2 months CA. We will conduct the analysis from
two perspectives: the public healthcare payer and society.
From the public payer’s perspective, we will include costs
incurred to the Ministry, namely birth hospitalization,
hospital readmissions, and emergency room and physician
visits additional to recommended health surveillance visits
for each infant enrolled in the study. In the detailed costs,
we will include laboratory tests, imaging, and medications.
From the societal perspective, we will include those costs
incurred by families while their infant(s) is/are in the
NICU, including parking, transportation, household sup-
port, missed work days, and childcare for siblings.
We will estimate total resource utilization cost as the
product of resource use and unit cost. We will obtain
unit costs from standard costing sources (e.g., Alberta
Wage and Salary Survey) [54] and relevant organizations
(e.g., the participating hospitals) [55]. After calculating
total healthcare cost, we will analyze it as a dependent
variable using regression to estimate the difference in ex-
pected healthcare cost between the two study groups.
We will use regression to allow for the adjustment of
potential confounders (e.g., demographic characteristics),
and to calculate the clustered standard errors using the
sandwich variance estimator attributed to Huber and
White [56] in order to account for a clustered random-
ized clinical trial. We will calculate a 95% confidence
interval to characterize the uncertainty. With a variety of
different types of regression (e.g., ordinary least squares,
generalized linear models), we will explore the impact of
various modeling assumptions [57, 58]. In addition, we
will compare parametric and non-parametric confidence
intervals using bootstrapping [59]. In theory, an ordinary
least-squares model produces unbiased estimates even
if the data are skewed; however, different estimation
methods (e.g., generalized linear models) and different
uncertainty methods (e.g., non-parametric bootstrap-
ping) will facilitate careful investigation of the impact
various assumptions have on our conclusions. We will
conduct a separate regression analysis for each perspec-
tive (public payer and society). In addition, we will use a
net benefit regression framework [60] to compare the
cost and effect of the FICare model against the standard
of care with effect being the LOS after birth. This ana-
lysis would produce an incremental net benefit of the
FICare model when compared to the standard of care at
various willingness-to-pay values. Findings from the eco-
nomic analysis of the FICare model may assist decision-
and policy-makers in the delivery of health services to
this important and specific population.
Data monitoring
We did not establish stopping guidelines or a data moni-
toring committee for this trial because FICare will be the
standard of care at intervention sites, and is expected to
enhance existing care, not cause harm. In addition, we
did not power the study for interim analysis of the
primary outcome.
Clinically, investigators have a professional responsibil-
ity to provide referrals for mothers who score at risk for
postnatal depression (i.e., scored 13 or greater on the
Edinburgh Postnatal Depression Scale (EPDS), or rated
item #10 as 1, 2 or 3 points to indicate suicidal ideation).
We check the database several times per week for EPDS
scores in the clinical range. If a mother scores in the
clinical range, the first author (KB) or a research associ-
ate with counseling psychology training will contact the
study nurse if the infant is still in the NICU, or contact
the mother at home if the infant(s) has/have been dis-
charged. The contacts will include a brief explanation of
the meaning of the EPDS score, and referral using the
relevant path for the mother in hospital (typically,
referred to social worker) or community (typically,
referred to public health or family physician) for second-
level screening, assessment and treatment, as appropriate.
Similarly, for infants who screen at risk for developmental
delay, we will contact mothers with a brief explanation
and inquiry about how the infant is doing.
Discussion
Our proposed pragmatic cRCT assesses an adapted
version of FICare that will be implemented with moder-
ate and late preterm infants admitted to Level II NICUs
in Alberta. The results will inform policy decisions by
providing evidence about the clinical effectiveness and
costs of FICare. To accomplish knowledge translation
(KT) goals, we will use both integrated and end-of-grant
KT strategies. Integrated KT strategies require the
inclusion of clinical and administrative leaders in the
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development and implementation of the intervention
and the study. We will focus on strategies to embed
components of FICare into existing structures and pro-
cesses. For example, for the FICare nurses, we will iden-
tify aspects of the study that can be used to demonstrate
learning to maintain annual nursing licensure. We will
provide enhanced education sessions at intervention
sites to ensure that changes in staff and competing
priorities do not interfere with study implementation.
We will use the Consolidated Framework for Implemen-
tation Research [53] to thoughtfully consider the barriers
and facilitators that are unique to each intervention site.
This work will enable our team to create a more fulsome
user’s manual to support scale and broad implementa-
tion, should FICare prove to be effective. Our final inte-
grated KT strategies focus on the inclusion of policy
decision-makers in our large team meetings where we
seek advice and guidance about the current initiatives in
the healthcare system and alignment of our results with
current directions. As the results from the study emerge,
we will carefully observe for synergistic effects of FICare
with other initiatives, as well as spin-offs such as
proposals to adapt and implement FICare component in
other populations and settings. Finally, our end-of-grant
KT will include traditional strategies such as manu-
scripts and conference presentations. Requirements for
authorship are outlined in our approved FICare Team
Handbook, and follow the International Committee of
Medical Journal Editors guidelines. Given the interest in
the FICare study, and engagement with policy decision-
makers at multiple levels in the healthcare system, we
have already been invited to share the progress of our
study with key stakeholder groups at provincial and
national meetings.
Trial status
On the date of manuscript submission, 352/659 mother/
infant dyads were enrolled in the trial.
Additional file
Additional file 1: SPIRIT Checklist. (DOCX 52 kb)
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